Connect with us

Technology

AIPOCH Launches Open-Science, Making Research Easier to Follow, Learn From, and Share with .science Packages

Published

2 days ago

on

An open-source AI research workbench with 23 built-in Skills, 525 marketplace Skills, 36 research connectors, and four agent frameworks—Claude Code, OpenCode, Codex, and CodeBuddy.

SINGAPORE, Oct. 14, 2026 /PRNewswire/ — AIPOCH today announced the formal public release of AIPOCH Open-Science, an open-source AI research workbench designed to help more people explore questions with AI, understand how results are produced, and share the work behind them. The release highlights .science packages, which bring selected conversation branches, file versions, notebook records, and verification evidence together, making the research process easier to follow, learn from, and share. This model has broad applicability and may become a new paradigm in the agent era. Whether for collaboration between people or the replication of expert experience, .science is an answer built for the agentic data transportability.

AIPOCH Open-Science is available now under the Apache License 2.0. A preprint describing AIPOCH Open-Science is available at https://arxiv.org/abs/2610.17110. Beyond AIPOCH, the paper’s authors are affiliated with 76 institutions worldwide. These institutions include medical centers such as Zhongshan Hospital of Fudan University, Amsterdam UMC, and Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital; universities such as Peking University, Shanghai Jiao Tong University, Zhejiang University, the University of Illinois Urbana-Champaign, and the Technion – Israel Institute of Technology; and technology and biotechnology companies such as SenseTime and Amoy Diagnostics. This breadth of collaboration shows that the AIPOCH Open-Science approach has been validated by many of the participating institutions. To learn more, visit https://aipoch.com/ or check the GitHub source at https://github.com/aipoch/open-science.

AIPOCH Open-Science brings AI agents together with research files, scientific literature, data sources, executable tools, local and remote computing resources, and research artifacts in one environment. Researchers can move from a research question to literature review, data analysis, visualization, reporting, and the preparation of a .science package without separating the reasoning interface from the working environment.

Open-Science covers the broader research workflow, providing an open-source environment where AI agents can work with scientific materials, execute computational tasks, and produce traceable research artifacts. .science packages support the preservation and transfer of the context behind that work, giving researchers a structured way to prepare projects for review, collaboration, handoff, and long-term archiving. AIPOCH Open-Science is informed by open standards such as RO-Crate, which describes research data, code, authors, licenses, and provenance together as a single exchangeable “research object.” This gives .science packages a portable, standards-based foundation, so that research context can be shared, reviewed, and archived across projects and institutions.

Addressing the Challenges of AI-Assisted Research

AI tools are increasingly used in scientific and technical work, but researchers still face several barriers to incorporating them into their workflows.

Scattered research context. AI-assisted research often requires transferring files and copying conversation histories separately, making the complete research context difficult to review, hand off, and build upon.

Fragmented workflows. Literature, PDFs, datasets, code, compute environments, notes, and final outputs live in disconnected tools. Researchers spend time moving across disconnected applications.

Vendor and model lock-in. Research teams may depend on a single provider or hosted environment. Organizations and individuals with self-developed or locally deployed models may also lack a flexible way to connect those models to research files, tools, and computing resources.

Opaque AI outputs. A polished answer or figure can be hard to evaluate when its source material, producing code, execution history, or intermediate decisions are missing.

Limited handoff and collaboration. Some AI research tools are designed primarily for individual use, which can make it difficult to share working context, hand off a project, or continue research across people and devices.

AIPOCH Open-Science addresses these challenges by making research context portable and inspectable through .science packages and a persistent workspace. A package can contain selected conversation branches, file versions, notebook records, and verification evidence. It can be shared with another researcher, moved to another computer, or imported as a read-only record for review. Researchers can fork it into a writable copy to build on the shared work.

Open-Science also brings the research workflow into a persistent, inspectable workspace, with support for multiple AI model providers and configurable execution environments. More than a research workbench, AIPOCH Open-Science works as a research operating system—a foundational environment where AI agents, models, data, tools, and computing resources operate together as parts of one coherent system. For instance, instead of switching between different tools at each stage of a project, users of AIPOCH Open-Science can access research capabilities in one unified workbench. Literature exploration, computational analysis, visualization, and reporting become connected steps in a single, coherent research process.

From Research Questions to Reproducible Artifacts

With AIPOCH Open-Science, users can describe a task in plain language and work with an AI agent to plan and execute research workflows. Subject to user permissions, agents can inspect research files, search approved sources, query scientific data connectors, and run Python, R, and shell workflows. The agent can create reports, tables, figures, notebooks, and other research artifacts that users can inspect and review.

Key capabilities include:

Portable .science packages. Open-Science pioneers the sharing of recorded AI-assisted working processes between machines. A .science package preserves an AI-assisted research session in a portable format. It allows work done on one system to be opened, inspected, and continued on another. Users can export selected conversation content and branches, file and artifact versions, notebook records, available provenance, and verification evidence for sharing, inspection, handoff, continuation, and archiving across projects or computers. After import, the record opens in read-only mode; it does not automatically execute code, restore credentials, or reuse the original external-service authorizations. Users can fork the imported record into a new writable copy to continue working. Reproducing an original result still depends on whether the exported inputs, code, dependencies, runtime, execution records, and any required external data are complete and still available.Integrated literature library. Researchers can organize references and PDFs, use AI agents to search and read library materials, and generate formatted citations and bibliographies. Smart Collections can optionally use a configured classification model such as Jev to screen references against user-defined inclusion and exclusion criteria, helping users build a focused reading set while keeping the results available for human review. BibTeX and RIS import and export connect the library with existing reference workflows.Open-source and model-agnostic architecture. Open-Science supports multiple AI model providers, agent frameworks, compatible custom gateways, locally deployed AI models, reusable Skills, and scientific connectors. Users can configure different models for different tasks, matching each task with a model suited to its requirements and strengths. Its codebase is available under the Apache License 2.0.Integrated code execution. AI agents can run Python, R, and shell workflows directly, enabling them to perform computational tasks rather than simply recommend code.Traceable research artifacts. Reports, tables, figures, and notebooks are preserved as immutable versions, with available connections to inputs, producer code, execution history, environment details, conversation branches, and optional reviewer evidence.User-controlled infrastructure. Project data is stored locally by default. Users can configure access permissions and connect compatible locally deployed AI models or external services, subject to their respective configurations and requirements.

An Open Ecosystem for Scientific Capabilities

AIPOCH Open-Science includes the Skill Marketplace which currently offers 525 Skills, and the Specialist Marketplace which includes 10 Specialists. Both marketplaces support contribution and review processes, enabling users to discover and install research capabilities directly within the workbench. Skills provide reusable scientific methods and tools, while Specialists combine instructions, Skills, and data tools into AI assistants for specific research scenarios.

By inviting researchers and developers worldwide to contribute Skills and Specialists, Open-Science is building a global open-source community. The goal is to make research capabilities easier to discover, reuse, and extend across disciplines.

“The era of Vibe Research is coming, where more people can turn their curiosity and research ideas into meaningful work,” said Huimei Wang, CEO of AIPOCH. “AIPOCH Open-Science brings open research tools, reusable scientific methods, and AI capabilities together in one workbench. We hope to make scientific exploration more accessible and build an open ecosystem where researchers and developers can contribute to and benefit from one another’s work.”

Designed for Scientific and Technical Workflows

AIPOCH Open-Science is designed to give researchers greater control over their tools, infrastructure, and working environment.

AIPOCH Open-Science supports research and technical workflows across life sciences, bioinformatics, statistics, machine learning, chemistry, materials science, physics, and environmental science.

The workbench is designed for researchers, students, educators, developers, engineers, analysts, and anyone with a desire to explore with AI. It helps users form hypotheses, analyze data, run computational experiments, interpret evidence, and produce reproducible research artifacts.

About AIPOCH

AIPOCH is building an open ecosystem for AI-powered scientific research. By bringing together AI agents, scientific tools, reusable methods, and research infrastructure, AIPOCH aims to make scientific capabilities more accessible and enable researchers and developers around the world to explore, build, and share new ways of doing research. Learn more at: https://aipoch.com/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/aipoch-launches-open-science-making-research-easier-to-follow-learn-from-and-share-with-science-packages-302908207.html

SOURCE AIPOCH

Related Topics:
Continue Reading

Technology

CRISPR Market worth $6.12 billion by 2031 – Exclusive Report by MarketsandMarkets™

Published

51 minutes ago

on

October 16, 2026

By

DELRAY BEACH, Fla., Oct. 16, 2026 /PRNewswire/ — According to MarketsandMarkets™, the CRISPR Market is projected to reach USD 6.12 billion by 2031 from USD 3.48 billion in 2026, at a CAGR of 12.0% during the forecast period.

Browse 388 market data Tables and 53 Figures spread through 319 Pages and in-depth TOC on “CRISPR Market – Global Forecast to 2031”

CRISPR Market Size & Forecast:

Market Size Available for Years: 2026–20312026 Market Size: USD 3.48 billion2031 Projected Market Size: USD 6.12 billionCAGR (2026–2031): 12.0%

CRISPR Market Trends & Insights:

North America accounted for the largest share, 49.7%, of the CRISPR market in 2025.By offering, products accounted for the largest share of 70.7% of the CRISPR market in 2025.By application, drug discovery & development accounted for the largest share of the CRISPR market in 2025.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134401204

The CRISPR market is expanding as pharmaceutical and biotechnology companies and academic & research institutes increasingly adopt gene-editing technologies to support drug discovery, functional genomics, therapeutic development, and agricultural research. CRISPR tools are widely used for gene knockout, knock-in, target identification and validation, disease modeling, cell line development, and high-throughput screening. Rising demand for precise, efficient genome editing is accelerating adoption of CRISPR kits & enzymes, libraries, gRNA solutions, and specialized screening and validation services. In addition, ongoing advances in CRISPR-Cas systems, gRNA design and optimization, base editing, prime editing, and gene delivery technologies are improving editing specificity, efficiency, and workflow scalability. The growing development of CRISPR-based therapies and wider application of gene editing across research and commercial settings are further supporting market expansion.

By offering, the products segment held the largest share of the CRISPR market in 2025.

By offering, the CRISPR market is segmented into products and services. In 2025, products accounted for the largest market share. This is mainly due to recurring demand for CRISPR kits, enzymes, libraries, guide RNAs, and other research consumables across gene-editing workflows. Pharmaceutical and biotechnology companies, as well as academic and research institutes, use these products for gene knockout, gene activation, functional genomics, target validation, and drug discovery. The growing adoption of CRISPR-based screening and increasing gene editing research further support product consumption. Continued development of advanced Cas enzymes, optimized guide RNA solutions, and ready-to-use CRISPR kits also supports the segment’s leading position.

By product type, the CRISPR kits & enzymes segment held the largest share of the CRISPR product market in 2025.

By product type, the CRISPR product market is segmented into CRISPR kits & enzymes, CRISPR libraries, and other products. In 2025, CRISPR kits & enzymes accounted for the largest market share. Their leading position is supported by their extensive use across routine gene editing, target validation, cell engineering, and functional genomics workflows. CRISPR kits provide researchers with standardized components for gene knockout, knock-in, and other genome editing experiments, while enzymes such as Cas9 and other Cas nucleases are core components of CRISPR workflows. Their broad applicability across pharmaceutical research, biotechnology R&D, and academic laboratories creates recurring demand. The availability of workflow-specific kits and improved CRISPR enzymes with enhanced editing performance further supports this segment’s dominance.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=134401204

By region, North America accounted for the largest share of the market in 2025.

In 2025, North America held the largest share of the CRISPR market. This is supported by strong biotechnology and pharmaceutical research activity, high investment in gene editing, and a well-established life sciences infrastructure. The US leads the region in CRISPR-based drug discovery, functional genomics, high-throughput screening, and therapeutic development. Leading CRISPR technology providers, biotechnology companies, academic research institutes, and pharmaceutical companies create strong demand for CRISPR products and services. Growing clinical development of gene-edited therapies and continued advancements in CRISPR-Cas systems, guide RNA technologies, and screening platforms further support market growth in North America.

Key Players

Leading players in the CRISPR companies include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), GenScript (US), Takara Bio (Japan), Creative Biogene (US), Fujian SunyBiotech Co., Ltd. (China), EditCo (US), Caribou Biosciences, Inc. (US), and Lonza (Switzerland), among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=134401204

CRISPR Market – Investment & funding +Merger & Acquisition

Investment Funding Context

The CRISPR market is seeing increasing investment and funding activity, driven by expanding gene-editing therapeutic pipelines, advances in CRISPR-Cas technologies, and the growing development of next-generation approaches such as base editing, prime editing, and epigenetic editing. Investment activity is increasingly focused on improving editing precision and delivery, advancing therapeutic candidates through clinical development, and expanding applications across genetic diseases and other therapeutic areas. For instance, in January 2025, Tune Therapeutics raised USD 175 million in Series B financing to advance its epigenetic editing platform and therapeutic pipeline. The financing highlights continued investor interest in differentiated gene-editing technologies with potential to address a broader range of diseases. This funding activity supports technology development, clinical translation, and commercialization across the CRISPR market.

Revenue Shift Context

The CRISPR market is gradually shifting revenue from conventional CRISPR-Cas9 systems and basic gene-editing reagents toward higher-growth categories such as engineered Cas nucleases, advanced CRISPR kits, high-throughput screening solutions, base editing, prime editing, and specialized gene-editing services. The global CRISPR market is projected to increase from USD 3.48 billion in 2026 to USD 6.12 billion by 2031, at a CAGR of 12.0%, with a growing share of incremental revenues expected from advanced editing platforms, customized gRNA solutions, CRISPR libraries, cell line development, and screening & validation services. Meanwhile, conventional Cas9-based products remain an important revenue base, but next-generation editing technologies and specialized services are gaining adoption across pharmaceutical & biotechnology companies and academic & research institutes.

Mergers and Acquisitions

Mergers and acquisitions in the CRISPR market are being driven by the need to strengthen gene-editing technology portfolios, gain access to proprietary CRISPR platforms, expand therapeutic development capabilities, and acquire expertise in next-generation editing and delivery technologies. Such transactions also enable companies to broaden their presence across drug discovery, functional genomics, and CRISPR-based therapeutic development.

CRISPR MARKET: MERGERS AND ACQUISITIONS, JANUARY 2023–SEPTEMBER 2026

Month & Year

Deal Type

Company 1

Company 2

Description

Deal Size

June 2025

Acquisition

Demeetra AgBio (US)

Hera BioLabs (US)

Demeetra acquired Hera BioLabs, bringing Super piggyBac licensing, development, and commercial activities under Demeetra. The acquisition expanded Demeetra’s genome-engineering portfolio and incorporated Hera’s in vitro capabilities into its internal R&D operations.

NA

July 2024

Acquisition

Agilent Technologies, Inc. (US)

BioVectra Inc. (Canada)

Agilent Technologies, Inc. (US) acquired BioVectra, Inc. (Canada), enhancing its biopharma solutions with BioVectra’s expertise in biologics and gene editing. The acquisition expanded Agilent’s drug development and manufacturing capabilities.

USD 925 Million

Company Revenue Share Details

The top four players collectively account for approximately 25-27% of the global CRISPR market, indicating a highly competitive landscape. This reflects established life sciences companies alongside specialized gene-editing technology and service providers. Key market participants include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), GenScript (US), Takara Bio (Japan), Creative Biogene (US), Fujian SunvBiotech Co., Ltd. (China), EditCo (US), Caribou Biosciences, Inc. (US), and Lonza (Switzerland). These companies compete across CRISPR kits & enzymes, libraries, gRNA solutions, cell line development, screening & validation, and other gene-editing services. Continued innovation in advanced CRISPR systems, editing optimization, high-throughput screening, and specialized services is further intensifying competition across the market.

Browse Adjacent Market: Biotechnology Market Research Reports &Consulting

See More Latest Medical Devices Reports:

Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (gRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-In), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) – Global Forecast to 2029

Genomics Market Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) – Global Forecast to 2030

About MarketsandMarkets™  

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/crispr-technology-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/crispr-technology.asp

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/crispr-market-worth-6-12-billion-by-2031—exclusive-report-by-marketsandmarkets-302911142.html

Continue Reading

Technology

Teachers Federal Credit Union Accelerates Strategic Branch Expansion Across New York and Florida

Published

51 minutes ago

on

October 16, 2026

By

New locations complement the credit union’s nationwide digital capabilities while strengthening member relationships and community connection

HAUPPAUGE, N.Y., Oct. 16, 2026 /PRNewswire/ — Teachers Federal Credit Union, one of the nation’s largest credit unions with $9.9 billion in assets and over 472,000 members, is continuing to expand its branch network across New York and Florida, with new locations planned for Estero and Wesley Chapel, Florida, and Farmingville, New York.

With a national open charter and members across all 50 states, Teachers combines the convenience of digital banking with access to personalized financial guidance. As the credit union’s membership has grown nationwide, its physical footprint has evolved alongside it, with continued investment in its home state of New York and an increasing presence in Florida. Teachers is also identifying additional markets across the country where a branch can bring the credit union closer to its members and support its long-term mission of helping members build a strong financial foundation today, for a better tomorrow.

“Our growth is guided by how we can better serve our members and support their financial well-being,” said Brad Calhoun, President and CEO of Teachers Federal Credit Union. “Our digital capabilities make it possible for us to serve members wherever they are, while our branches provide opportunities to build personal relationships and offer guidance through the financial moments that matter most. As we continue to expand in New York, strengthen our presence in Florida, and enter new markets, we remain focused on giving members more convenient ways to connect with Teachers and access the personalized service, expertise, and support they value – wherever and whenever they need us.”

To help guide its branch strategy, Teachers partnered with global commercial real estate services firm JLL to conduct a market screening.

“Establishing our partnership with JLL was an important step in developing our approach to branch expansion. We wanted to understand where our members are, what markets are evolving, and where a physical presence could create the greatest opportunity for Teachers,” added Inna Sprague, Chief Experience Officer, Teachers Federal Credit Union. “We combined internal data with factors such as market growth, demographics, competition, and site characteristics of potential locations to develop a branch expansion strategy that aligned with member needs, market opportunity, and our broader growth goals.”

Teachers has steadily expanded its branch network in recent years, entering the Florida market with its first location in Tampa’s Westshore district in 2023 and building on that presence with branches in Naples in 2025 and Lake Mary, serving the greater Orlando region, in 2026. In New York, Teachers opened a new branch in Holbrook in 2025 and continues to invest in its Long Island footprint. The planned locations in Estero, Wesley Chapel, and Farmingville represent the next phase of that strategy, expanding access in markets where Teachers sees opportunities to serve both existing and future members.

As Teachers grows, its investment in the communities it serves grows with it. The credit union’s approach extends beyond opening branches to supporting organizations and causes that make a meaningful difference in the places where its members live and work. Through its annual Golf Tournament benefiting Children’s Miracle Network, Teachers has raised more than $3 million since 2023 to support children and families, including through partnerships with Cohen Children’s Medical Center in New York and Johns Hopkins All Children’s Hospital and Nicklaus Children’s Hospital in Florida. Teachers also supports the American Cancer Society through Making Strides Against Breast Cancer, serving in 2026 as Presenting Sponsor on Long Island and Eastern Long Island and Silver Sponsor in Tampa Bay and Southwest Florida.

For more information about Teachers Federal Credit Union, please visit www.teachersfcu.org

About Teachers Federal Credit Union
Teachers Federal Credit Union (Teachers) is one of the country’s largest credit unions, with $9.9 billion in assets and over 472,000 members across all 50 states. Founded in New York in 1952, Teachers is a full-service, not-for-profit financial institution with an open charter offering membership to anyone in the U.S. through its 33 full-service branches and best-in-class digital solutions. Teachers is a key supporter of the communities it serves and is proud to offer a range of member-focused products with competitive rates and low fees. What started as a smart solution for teachers is now smart for all. For more information, visit www.teachersfcu.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/teachers-federal-credit-union-accelerates-strategic-branch-expansion-across-new-york-and-florida-302911362.html

SOURCE Teachers Federal Credit Union

Continue Reading

Technology

Renewable Energy Tax Credit Professionals to Explore Changing Energy Policy Landscape at Novogradac Conference

Published

51 minutes ago

on

October 16, 2026

By

Novogradac to Host 2026 Fall Renewable Energy Tax Credits Conference, Nov. 5-6 in Washington, D.C.

SAN FRANCISCO, Oct. 16, 2026 /PRNewswire/ — Clean energy professionals will gather to receive actionable, technical insights into navigating the evolving renewable energy tax credit (RETC) market at the Novogradac 2026 Fall Renewable Energy Tax Credits Conference, Nov. 5-6 at the Fairmont Washington, D.C. Georgetown.

Set at a pivotal moment for the renewable energy market and immediately after the 2026 mid-term elections, this conference will bring together attorneys, developers, investors, lenders, tax insurance providers and advisors to examine the policy, structuring and financing issues shaping RETC investments. Attendees will engage with practical, technically focused content regarding deal execution, market developments and the challenges industry professionals are facing.

Sessions at the conference will discuss recent federal developments affecting clean energy tax incentives, technical tax considerations shaping deal execution, the clean energy development landscape and how it is evolving, what is driving investor interest in certain properties, tax equity structures and more. The full conference agenda can be found here.

“This year, the RETC sector has been shaped by major changes in federal policy and guidance. It’s important to stay up to date with the current state of the market,” said Tony Grappone, a partner in Novogradac’s North Andover, Massachusetts, office and chair of the conference. “This conference offers a targeted experience centered on technical content and represents an opportunity to connect with other professionals facing similar challenges.”

The Novogradac 2026 Fall Renewable Energy Tax Credits Conference is co-hosted by Bildmore, CAC, Crux, Foley and Lardner, Monarch Private Capital, Nixon Peabody and Raymond James. Conference sponsors include Alliant, Alston & Bird, Aon, Concentro, Crowell & Moring, DLA Piper, Euclid Transactional, Foley Hoag, Foss & Company, Howden, Key State, Latham & Watkins, Lux Speed Capital, National Trust Energy Capital, Reunion, Ryan, Sugar Creek Capital and Summit Ridge Energy. Kutak Rock and Prince Lobel will be exhibitors at the conference.

Novogradac will host a pre-conference workshop Wednesday, Nov. 4. The Project Finance Primer: Fundamentals & Monetization workshop will provide insights into financing clean energy developments by using tax credits as part of the capital stack. Topics of discussion will include the state of the market, what incentives are available, various tax equity structures and hot topics such as foreign entities of concern, prevailing wage and apprenticeship, domestic content and more. Separate registration fees apply for the pre-conference workshop.

About Novogradac
Novogradac, which has been in business for more than 35 years, has grown to more than 800 employees and partners with offices in more than 25 cities. Tax, audit and consulting specialty practice areas for Novogradac include affordable housing, community development, historic rehabilitation and renewable energy. For additional information on Novogradac’s personnel and areas of expertise, visit www.novoco.com or call (415) 356-8000.

View original content:https://www.prnewswire.com/news-releases/renewable-energy-tax-credit-professionals-to-explore-changing-energy-policy-landscape-at-novogradac-conference-302910360.html

SOURCE Novogradac & Company LLP

Continue Reading

Trending